Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Depreciation & Amortization (CF) (2018 - 2025)

Historic Depreciation & Amortization (CF) for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $612000.0.

  • Exagen's Depreciation & Amortization (CF) rose 4502.37% to $612000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 644.27%. This contributed to the annual value of $1.7 million for FY2024, which is 2047.97% down from last year.
  • Latest data reveals that Exagen reported Depreciation & Amortization (CF) of $612000.0 as of Q3 2025, which was up 4502.37% from $466000.0 recorded in Q2 2025.
  • In the past 5 years, Exagen's Depreciation & Amortization (CF) registered a high of $612000.0 during Q3 2025, and its lowest value of $187000.0 during Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $440000.0 (2022), whereas its average is $416578.9.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first skyrocketed by 9540.64% in 2023, then tumbled by 3024.79% in 2024.
  • Quarter analysis of 5 years shows Exagen's Depreciation & Amortization (CF) stood at $292000.0 in 2021, then soared by 78.08% to $520000.0 in 2022, then fell by 2.5% to $507000.0 in 2023, then fell by 18.15% to $415000.0 in 2024, then skyrocketed by 47.47% to $612000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $612000.0 for Q3 2025, versus $466000.0 for Q2 2025 and $440000.0 for Q1 2025.